Clinical trial
A Randomized, Prospective, Double-Blind Study Comparing Fluconazole With Placebo for Primary and Secondary Prophylaxis of Mucosal Candidiasis in HIV-Infected Women
NCT00000744
Study timeline
Registry last updated2021-11-03
Observed by CureCurrent2026-10-07
Recorded dates are source observations, not predictions. Missing milestones are not estimated.
Conditions
Interventions
FluconazoleDRUG · verified · RxNorm: fluconazole
Sponsors & collaborators
Pfizercollaborator
Mapped research locations
New YorkNew York, United States2DetroitMichigan, United States2ChicagoIllinois, United States1AtlantaGeorgia, United States1San FranciscoCalifornia, United States1PortlandOregon, United States1Washington D.C.District of Columbia, United States1DenverColorado, United States1RichmondVirginia, United States1The BronxNew York, United States1New OrleansLouisiana, United States1BrooklynNew York, United States1
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT00000744 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.